Speakers

Workshop Day
Speakers
CAR-TCR 101 Bootcamp Speakers
Regulatory Bootcamp Speakers
Main Agenda
Speakers
Focus Day
Speakers

Workshop Day Speakers

Dan Bright

Director - Manufacturing Operations

Cellectis

Grace Zheng

Director - Data Analytics

Arsenal Biosciences

Reagan Jarvis

CEO

Anocca AB

Siler Panowski

Director - Biology & Solid Tumors

Allogene Therapeutics

Steward Abbot

Chief Scientific & Operating Officer

Adicet Bio Inc.

Alex Karlsson-Parra

Interim Chief Executive Officer & Chief Scientific Officer

Immunicum

Filiz Yucebay

Manager, Pharmacy Consultant

Huron Consulting Group

Gregory Frost

Chairman & CEO

Exuma Biotechnology

Santanu Das

Managing Director, Life Sciences Practice

Huron Consulting Group

Adrian Bot

Vice President - Scientific Affairs & Translational Medicine

Kite Pharma Inc

Dirk De Naeyer

Chief Operating Officer

Kiadis Pharma

Hari Kamaraju

Director, Advanced Therapies Supply Chain

Johnson & Johnson

Aman Singh

Associate Director, Clinical Pharmacology M&S

Takeda Pharmaceutical Co. Ltd.

Beau Webber

Assistant Professor

University of Minnesota-Twin Cities

David Martin

Chief Executive Officer & Co-Founder

Xyphos

Weirong Wang

Scientific Director

Johnson & Johnson

Gary Lee

Chief Scientific Officer

Senti Biosciences Inc.

Kurt Gunter

Chief Medical Officer

Kuur Therapeutics

Renier Brentjens

Director, Cellular Therapeutics

Memorial Sloan Kettering Cancer Center

Roman Yelensky

Executive Vice President & Chief Technology Officer

Gritstone Oncology

CAR-TCR 101 Bootcamp Speakers

Blake Aftab

VP of Research

Adicet Bio

Hemant Dhamne

Head of Vector & CAR-T Cell Processing

Immuneel Therapeutics Pvt. Ltd.

Indu Ramachandran

Director, Head of Translational Development

Century Therapeutics

Marvin Gee

Co-Founder & Head of Target Discovery

3T Biosciences

William Go

Senior Vice President & Head of Development

A2 Biotherapeutics

Christopher Kloss

Assistant Principal Scientist, Cell & Process Designer

Merck & Co

Faraz Zaman

Director & Lead - Global Medical

Amgen Inc.

Moonsoo M Jin

Associate Professor - Biomedical Engineering & Radiology

Weill Cornell - Cornell University

William Schaut

Senior Manager

Janssen Global Services, LLC

Regulatory Bootcamp Speakers

Agnes Yeboah

Executive Director, Global Regulatory CMC, Biologics & Cell Therapy

Bristol-Myers Squibb

Elena Spanjaard

Global Head of Regulatory Affairs

Celyad

Mingxiao He

Process Development Scientist III

Eureka Therapeutics

Peter Marks

Director - Biologics Evaluation & Research

US Food & Drug Administration (FDA)

Laura Pearce

Senior Director - Oncology Cell, Gene Therapy & Clinical Development Lead

GlaxoSmithKline

Manisha Patel

Global Program Regulatory Director - Oncology CAR-T Therapy Program

Novartis

Nadia Agopyan

Vice President - Regulatory Affairs

Marker Therapeutics, Inc.

Renu Vaish

VP Global Regulatory Affairs

Kite Pharma Inc

Main Agenda Speakers

Hans-Peter Gerber

Chief Scientific Officer

3T Biosciences

Helen Tayton- Martin

CBO

Adaptimmune

Joanna Brewer

SVP Allogeneic Research

Adaptimmune

Peter Smith

Chief Executive Officer

Affinity Bio

Sanjay Srivastava

Managing Director Cell & Gene Therapy CoE Lead

Accenture

Balwant Patel

Vice President of Marketing and Portfolio Management

Akron Biotech

Barbra Sasu

Chief Scientific Officer

Allogene Therapeutics

Janet Lynch Lambert

CEO

Alliance for Regenerative Medicine

Paul Rennert

President & CSO

Aleta Biotherapeutics

Rafael Amado

Executive Vice President, Chief Medical Officer & Head of Research & Development

Allogene Therapeutics

Brent Rice

Vice President - Global Market Access

Autolus

Joy Aho

Senior Product Manager

BeTheMatch

Ravi Kapur

CEO

BendBio

Stephen Santoro

Director

Arsenal Biosciences

Vasiliki Zochiou

Research Analyst, Beacon Adoptive Cell

Beacon Targeted Therapies

Art Malian

Executive Director - Information Technology Cell Therapy Digital Platform

Bristol-Myers Squibb

Desiree Otenti

Senior Director, Medical Policy & Program Implementation

Blue Cross & Blue Shield of Massachusetts

Krishnan Viswanadhan

Senior Vice President - Global Cell Therapy & Franchise Lead

Bristol-Myers Squibb

Kristen Hege

Senior Vice President - Early Clinical Development, Hematology, Oncology & Cell Therapy

Bristol-Myers Squibb Co.

Melinda Mast

Executive Director - Global Patient Operations

Bristol-Myers Squibb Co.

Ashish Kothari

Medical Director, Cell Transplant Therapy

CareDx

David Lewandowski

Global Business Development Manager, Cryo Division

Brooks Life Science

Rachel Haurwitz

President & Chief Executive Officer

Caribou Biosciences

Steven Kanner

Chief Scientific Officer

Caribou Biosciences

Travis Young

Vice President & Director - Biologics & Protein Sciences

The Scripps Research Institute

David Gilham

Chief Scientific Officer

Celyad

Deborah Rathjen

CEO

Carina Biotech

Fabian Gerlinghaus

Co-Founder & Chief Executive Officer

Cellares

John Rossi

SVP & Head of Translational Medicine

CERo Therapeutics

Michael Klichinsky

Co Founder & Senior Vice President - Research

Carisma Therapeutics

George O’sullivan

Head of Supply Chain

Elevate Bio

Jennifer chow

COO

Chimeric Therapeutics

Luis Borges

Chief Scientific Officer

Century Therapeutics

Saul Priceman

Assistant Professor

City of Hope National Medical Center

Tony Ho

Executive Vice President & Head of Research & Development

CRISPR Therapeutics

Bob Valamehr

Chief Development Officer & Vice President - Cancer Immunotherapy

Fate Therapeutics

Cheng Liu

President & CEO

Eureka Therapeutics

Gregory Fiore

CEO

Exacis Biotherapeutics

Jane Grogan

Formerly Head of Adaptive Cell Therapy & IO

Genentech

Yan Chen

CEO

Elpis Biopharmaceuticals

Axel Hoos

Senior Vice President & Head of Therapeutic Area Oncology, Research, Development & Governance Chair

GlaxoSmithKline

Bangwen Xie

Flow Cytometry Expert

GlaxoSmithKline

Chris Baldwin

Director - Supply Chain & Cell & Gene Therapy

GlaxoSmithKline

Kenneth Warrington

Senior BD Director

GenScript ProBio

Rizwan Romee

Associate Professor & Director - Haploidentical Donor Transplant Program

Dana-Farber Cancer Institute

Arun Anand

Chief Operating Officer

Immuneel Therapeutics Pvt. Ltd.

Delfi Krishna

Head of Strategic Operations Cell & Gene Therapy

Immatics GmbH

Harpreet Singh

Managing Director, President & Chief Executive Officer

Immatics GmbH

Maya Khurana

Director - Market Access & Commercial Strategy

Huron Consulting Group

Sarabvijay Singh

Senior Director

Huron Consulting Group

Bharathi Vellalore

Scientist, Drug Product Development Discovery, Product Development and Supply

Johnson & Johnson

Jean Stanton

Director - Commercial Apheresis Operations

Johnson & Johnson

Lei Xiao

Chief Executive Officer

Innovative Cellular Therapeutics

Mark McKee

VP, Clinical Development

Intellia Therapeutics

Sean Mackay

CEO & Co-Founder

IsoPlexis

Etyan Abraham

VP, Head of Personalized Medicine Business Unit

Lonza

John Maher

CSO

Leucid Bio

John Tomtishen

Director - Manufacturing, Technical Operations

Legend Biotech

Margo Roberts

Formerly CSO

Lyell Immunopharma

Niti Shah

Vein to Vein Supply Chain Lead

Legend Biotech

Allison Matthews

Service Design Researcher

Mayo Clinic

Barb Geiger

SVP Clinical Operations

Mana Therapeutics

Emily Titus

Vice President - Process Sciences

Notch Therapeutics

Mythili Koneru

Chief Medical Officer

Marker Therapeutics, Inc.

Rogier Reijmers

Principal Scientist & Head of Validation Research

Lumicks

Courtney Cambouris

NGS specialist / Sales Manager

PathoQuest

Martin Giedlin

Senior Vice President

PACT Pharma Inc.

Shyam Subramanian

Vice President & Head of Technical Development & Manufacturing

Obsidian Therapeutics

Stefan Hendriks

Global Head of Cell & Gene

Novartis Oncology

Steven Wiltgen

North America Director of Commercial Operations

Ovizio

Devon Shedlock

Senior Vice President - Research & Development

Poseida Therapeutics

Dolores J. Schendel

Chief Executive Officer & Chief Scientific Officer

Medigene AG

Eric Ostertag

Chief Executive Officer

Poseida Therapeutics

Jason Bock

Vice President & Head of Biologics Product Development & Therapeutics Discovery

M D Anderson Cancer Center Orlando

Nirav Shah

Assistant Professor - Hematology and Oncology

Medical College of Wisconsin

Bing Wang

Chief Executive Officer

Refuge Biotechnologies

Christian Klein

Distinguished Scientist & Head of Department, Oncology Programs & Cancer Immunotherapy Discovery 3

Roche

Luca Gattinoni

Chair for Functional Immune Cell Modulation

Regensburg Center for Interventional Immunology

Nick Brown

Senior North American Business Development Manager

Retrogenix

Stefan Wild

Senior Manager, Research and Development

Miltenyi Biotec

Aaron Foster

Vice President - Immunology

Sana Biotechnology

Heather Erickson

Vice President - Supply Chain Management & Business Operations

Sangamo Therapeutics

Michael Laska

Vice President - Process Development & Manufacturing

Sana Biotechnology

Sonja Schrepfer

Founder - Scientific & Head of Hypo-Immune Platform, Senior Vice President, Professor

Sana Biotechnology

Steven Harr

President, Co-Founder & Chief Executive Officer

Sana Biotechnology

Kirstin Powel

VP, QA

Talaris Therapeutics

Patrick Melvin

Vice President, Oncology, New and Emerging Therapies

Syneos Health

Philip Lee

Co-Founder & Chief Operating Officer

Senti Biosciences Inc.

Robert Lechich

Principal Manufacturing and Supply Chain Consultant

Global OT/IT QS

Shabnum Patel

Associate Director

Stanford University

Don Healey

CTO

Adicet Bio

Donna Rill

Chief Technology Officer

Triumvira Immunologics Inc

Joseph McGuirk

Director of HMCT

University of Kansas Medical Center

Robert Hofmeister

Chief Scientific Officer

TCR2 Therapeutics

Ryan Crisman

Co Founder & Chief Technology Officer

Umoja Biopharma

Carl June

Professor - Pathology & Laboratory Medicine

University of Pennsylvania

Jakob Dupont

EVP, Head of Global Research & Development

Atara Biotherapeutics

Robert Richards

Administrative Director, Cell Therapy and Transplant

University of Pennsylvania

Shon Green

Senior Director of Translational Sciences

Umoja Biopharma

Yi Fan

Assistant Professor - Radiation Oncology

University of Pennsylvania

Jonathan Wofford

General Manager Cellular Therapy Solutions

WellSky

Josh Ludwig

US Commercial Director

ScaleReady

Maria Whitman

Managing Principal

ZS Associates

Sankalp Sethi

Principal

ZS Associates

Focus Day Speakers

Gillian Payne

Executive Director - Analytical Development

CRISPR Therapeutics

Michael Lehmicke

Director, Science and Industry Affairs

Alliance for Regenerative Medicine

Murat Kalayoglu

Chief Executive Officer

Cartesian Therapeutics

Pascal Touchon

Chief Executive Officer & President

Atara Biotherapeutics

Samik Basu

Vice President - Preclinical & Translational Research

Cabaletta Bio

Ken Chen

Assistant Professor - Bioinformatics & Computational Biology, Bioinformatics & Computational Biology

MD Anderson Cancer Center

Kim Nguyen

Vice President - Chemistry, Manufacturing & Controls

Precision BioSciences, Inc

Nina Timberlake

Associate Director, Gene Therapy

Poseida Therapeutics

Tam Soden

Executive Director & Global Head of Quality Control

Kite Pharma Inc

Tamara Laskowski

Director - Project Scientific

MD Anderson Cancer Center

Christian Homsy

CEO & Founder

Teefib

Joaquin Arribas

Head of Growth Factors Laboratory & Director - Preclinical Research

Vall d' Hebron Research Institute (VHIR)

Roderick O’Connor

Assistant Professor - Research & Instructor - Cell &Tissue Biology

University of Pennsylvania

Scott Kitchen

Director & Associate Professor - Medicine

University of California Los Angeles

FULL EVENT GUIDE
REGISTER
Back to Top